Noriaki Nakaya

Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis

Mitsuhiro Yokoyama, Hideki Origasa, Masunori Matsuzaki et al. · The Lancet · 2007 · 2.5K citations

Metabolic Syndrome, Hypercholesterolaemic Patients, Cardiovascular Disease +8

Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial

Haruo Nakamura, Kikuo Arakawa, Hiroshige Itakura et al. · The Lancet · 2006 · 949 citations

Non-pharmacological Intervention, Primary Prevention, Preventive Medicine +11

Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: Sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS)

Yasushi Saitō, Mitsuhiro Yokoyama, Hideki Origasa et al. · Atherosclerosis · 2008 · 318 citations

Hypercholesterolemic Patients, Cardiovascular Disease, Health Policy +9

Large Scale Cohort Study of the Relationship Between Serum Cholesterol Concentration and Coronary Events With Low-Dose Simvastatin Therapy in Japanese Patients With Hypercholesterolemia. Primary Prevention Cohort Study of the Japan Lipid Intervention Trial (J-LIT).

Masunori Matsuzaki, Toru Kita, Hiroshi Mabuchi et al. · Circulation Journal · 2002 · 261 citations · Full text

Relationships between Plasma Fatty Acid Composition and Coronary Artery Disease

Hiroshige Itakura, Mitsuhiro Yokoyama, Masunori Matsuzaki et al. · Journal of Atherosclerosis and Thrombosis · 2011 · 215 citations · Full text